WIB-RTP and the American Medical Writers Association (AMWA) are excited to partner for an evening of exploring how artificial intelligence is transforming the future of drug development, commercialization, and healthcare innovation.

This event will bring together leaders across science, industry, technology, and policy to discuss the rapidly evolving role of AI in pharmaceuticals, including its impact on drug discovery, clinical development, regulation, intellectual property, and precision medicine.